Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi

International Journal of Tuberculosis and Lung Disease

Volumn 6, Issue 12, 2002, Pages 1046-1050

  Zachariah, Rony ^a,d   Spielmann, M P ^a   Harries, A D ^b   Gomani, P ^c   Bakali, E ^c  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b Advisory Unit   (Malawi)

^c Ministry of Health/Population   (Malawi)

^d Medecins Sans Frontieres Luxembourg   (Luxembourg)

Author keywords

Cotrimoxazole; HIV; Malawi; Tuberculosis

Indexed keywords

COTRIMOXAZOLE; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DRUG COST; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAWI; MALE; OPPORTUNISTIC INFECTION; PATIENT COUNSELING; PRIORITY JOURNAL; QUESTIONNAIRE; RURAL HEALTH CARE; TUBERCULOSIS;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALAWI; MALE; MIDDLE AGED; RURAL POPULATION; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUBERCULOSIS;

EID: 0036924018     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. De Cock K M, Soro B, Coulibaly I M, Lucas S B. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992; 268: 1581-1587.
2. Raviglione M C, Harries A D, Msiska R, Wilkinson D, Nunn P. Tuberculosis and HIV: Current status in Africa. AIDS 1997; 11 (Suppl B): S115-S123.
3. Gilks C F, Brindle R J, Otieno L S, et al. Life-threatening bacteraemia in HIV-1-seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 1990; 336: 545-549.
4. Brindle R J, Nunn P P, Batchelor B I F, et al. Infection and morbidity in patients with tuberculosis in Nairobi, Kenya. AIDS 1993;7:1469-1474.
5. Greenberg A E, Lucas S, Tossou O, et al. Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Cote d'Ivoire. AIDS 1995; 9: 1251-1254.
6. Wiktor S Z, Sassan-Morroko M, Grant A D, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1 infected patients with tuberculosis in Abidjan, Cote d'Ivoire: A randomised controlled trial. Lancet 1999; 353: 1469-1475.
7. Provisional WHO/UNAIDS Secretariat Recommendations on the Use of Cotrimoxazole Prophylaxis in Adults and Children Living with HIV/AIDS in Africa. Geneva, Switzerland: UNAIDS, 2000.
8. Zachariah R, Harries A D, Spielmann M P, et al. Cotrimoxazole Prophylaxis in HIV Positive TB Patients in a Rural District of Malawi. Abstract TuOrB278. Durban, South Africa: XIII International AIDS Conference, 2000.
9. Manual of the National Tuberculosis Control Programme in Malawi. 1999 4th ed. Lilongwe, Malawi: Ministry of Health and Population.
10. Zachariah R, Harries A D, Arendt V, et al. Compliance with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-positive tuberculosis patients in Thyolo district, Malawi. Int J Tuberc Lung Dis 2001; 5: 843-846.
11. Zachariah R, Spielmann M P, Harries A D, Salaniponi F M L. Moderate to severe malnutrition in patients with tuberculosis is a risk factor associated with early death. Trans Soc Trop Med Hyg 2002; 96: 291-294.
12. World Health Organization Communicable Diseases. WHO Report 2001. Global Tuberculosis Control. WHO/CDS/TB/ 2001.287. Geneva: WHO, 2001.
13. Harries A D, Hargreaves N J, Kemp J, et al. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet 2001; 357: 1519-1523.